Status:
COMPLETED
Transitional Cerebrovascular Reactivity in Very Preterm Infants
Lead Sponsor:
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Conditions:
Cerebral Autoregulation
Preterm Birth
Eligibility:
All Genders
1-3 years
Brief Summary
The transitional period, defined as the first 72 hours after preterm birth, is often characterized by a significant hemodynamic instability and may also be associated with an impairment of cerebral au...
Detailed Description
The transitional period, defined as the first 72 hours after preterm birth, is often characterized by a significant hemodynamic instability and may also be associated with an impairment of cerebral au...
Eligibility Criteria
Inclusion
- gestational age \<32 weeks' gestation
Exclusion
- major congenital malformations
- congenital heart disease
Key Trial Info
Start Date :
February 21 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 3 2021
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT04423016
Start Date
February 21 2018
End Date
July 3 2021
Last Update
July 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sant'Orsola-Malpighi University Hospital
Bologna, Emilia-Romagna, Italy, 40138